ADAMTS13 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NB100-584
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Goat IgG
Concentration
1.0 mg/ml
Product Specifications
Immunogen
A synthetic peptide which maps to a region between residues 250 and 350 of human A Disintegrin-like and Metalloprotease (reprolysin type) with Thrombospondin type 1 motif, 13 using the numbering given in entry XP_088414.1 (GeneID 11093).
Specificity
NB100-584 is specific for human ADAM TS13 protein.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Scientific Data Images for ADAMTS13 Antibody
Western Blot: ADAMTS13 Antibody [NB100-584]
Western Blot: ADAMTS13 Antibody [NB100-584] - Purified recombinant Adam-TS13. Antibody used at the indicated concentrations.Applications for ADAMTS13 Antibody
Application
Recommended Usage
Western Blot
1:100-1:1000
Application Notes
NB 100-584 has been shown to react with purified recombinant ADAM-TS13 in Western Blot. It has not been tested for reactivity with ADAM-TS13 from native sources, and the antibody is not warranted to have such activity. The suggested WB dilution is for recombinant protein.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
Tris-Citrate/Phosphate (pH 7.0 - 8.0)
Preservative
0.09% Sodium Azide
Concentration
1.0 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C. Do not freeze.
Background: ADAMTS13
Long Name
A Disintegrin-like and Metalloproteinase Domain with Thrombospondin Motifs 13
Alternate Names
TTP, vWF-CP
Entrez Gene IDs
11093 (Human)
Gene Symbol
ADAMTS13
Additional ADAMTS13 Products
Product Documents for ADAMTS13 Antibody
Product Specific Notices for ADAMTS13 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...